GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Model N Inc.
The historical performance of Model N, a provider of revenue management software for pharmaceutical companies, reflected the stability of its niche business. Its history culminated in a buyout by private equity firm Vista Equity Partners in 2024.
Share prices of companies in the market segment - It med
Model N provides cloud-based revenue management software for pharmaceutical and technology companies, helping them optimize pricing and discounts. We've categorized it as "Medical IT." The chart below shows how the market values niche enterprise software.
Broad Market Index - GURU.Markets
Model N is a company that provides cloud-based revenue management software for pharmaceutical and technology companies. As a leader in its niche, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Model N's performance to assess the state of the sector.
Change in the price of a company, segment, and market as a whole per day
MODN - Daily change in the company's share price Model N Inc.
Model N, Inc.'s daily price change reflects volatility in the enterprise software sector. The metric demonstrates sensitivity to demand for its revenue management solutions from pharmaceutical and technology companies.
Daily change in the price of a set of shares in a market segment - It med
Model N provided cloud-based revenue management software for pharmaceutical and technology companies. Its acquisition by a private equity firm exemplifies the trend of tech companies going public. The chart below illustrates the volatility in the software sector, which could make private ownership attractive.
Daily change in the price of a broad market stock, index - GURU.Markets
Model N is a SaaS platform that helps pharmaceutical companies manage pricing and contracts. Its business serves as a barometer of the health and complexity of the pharmaceutical industry. Its stock price reflects these trends and is part of the overall picture.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Model N Inc.
Model N, Inc.'s year-over-year performance tells the story of its niche software. Its 12-month market cap growth reflects demand for its revenue management platform from pharmaceutical and technology companies, as well as its recent decision to go private, a key event for its shareholders.
Annual dynamics of market capitalization of the market segment - It med
Model N is a leader in revenue management software for pharmaceutical and technology companies. The company is in the process of being privatized. Its stock price reflects the terms of the acquisition rather than its operating results, making its performance different from other players in the sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Model N, a provider of cloud-based revenue management software for pharmaceutical and technology companies, is solving a complex but important problem. Its year-over-year market capitalization reflects the demand for specialized software in these industries. It is a niche B2B player with a stable customer base.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Model N Inc.
Model N provides cloud-based revenue management software for the pharmaceutical and tech industries. Its monthly performance reflected subscriber growth. However, its recent performance has been entirely driven by news of its acquisition by Vista Equity Partners, with the stock price aligning with the deal price.
Monthly dynamics of market capitalization of the market segment - It med
Model N, Inc. is a leading provider of cloud-based revenue management solutions for pharmaceutical and technology companies. Its sector dynamics, shown in the chart, reflect trends in IT. Against this backdrop, one can see how its specialized software, which helps manage complex pricing and discounts, is becoming critical for its clients.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Model N provides cloud-based revenue management software for pharmaceutical and high-tech companies. Its stock moves in tandem with these sectors. The chart will show how much the company's performance depends on the health of its key customers and how it competes in its niche, which determines its position relative to the market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Model N Inc.
Model N, a provider of cloud-based revenue management solutions for pharmaceutical and high-tech companies, whose weekly stock price reflects demand for specialized software. Customer growth and competition shape short-term trends, revealing the pulse of these industries.
Weekly dynamics of market capitalization of the market segment - It med
Model N and the entire niche enterprise software sector are responding to general trends in their respective industries—pharma and high tech. Costs associated with pricing optimization are a common driver. The chart below will show how the company compares against this backdrop.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Model N provides cloud solutions for pharmaceutical and high-tech companies. Its business relies on corporate IT budgets. The chart below shows how MODN shares, as a technology asset, react to overall market sentiment.
Market capitalization of the company, segment and market as a whole
MODN - Market capitalization of the company Model N Inc.
The Model N chart is a financial calculator for the pharmaceutical and technology industries. The market capitalization of this company, whose software helps manage complex pricing, discounts, and contracts, reflects the need to automate these processes. Its dynamics are a barometer of the importance of precise and effective revenue control for these industries.
MODN - Share of the company's market capitalization Model N Inc. within the market segment - It med
Model N provides revenue management software for pharmaceutical and technology companies. Its market capitalization in the IT sector reflects its dominant position in this complex niche. The company's size reflects the importance of pricing and discount optimization in these industries.
Market capitalization of the market segment - It med
Model N provides cloud-based revenue management software for pharmaceutical and technology companies. The chart below shows the total market capitalization of the entire enterprise software sector. Its growth reflects the complexity of pricing and discounting in these industries.
Market capitalization of all companies included in a broad market index - GURU.Markets
Model N is a provider of cloud-based revenue management software for pharmaceutical and technology companies. Its market capitalization chart tells the story of the complex "math" of pricing. It shows how software that helps manage discounts and contracts creates value.
Book value capitalization of the company, segment and market as a whole
MODN - Book value capitalization of the company Model N Inc.
For Model N, a developer of revenue management software, book value is minimal. The chart below shows a modest tangible asset base. The company's main asset is its niche SaaS platform for pharmaceutical and high-tech companies, which is intangible.
MODN - Share of the company's book capitalization Model N Inc. within the market segment - It med
Model N is a provider of cloud-based revenue management software for pharmaceutical and high-tech companies. It's a pure software business. Its share of physical assets will tend toward zero, demonstrating its role as the "brain" behind pricing without owning any of its clients' tangible assets.
Market segment balance sheet capitalization - It med
The chart shows the book value of the IT sector. Against this backdrop, Model N, as a provider of revenue management software for pharmaceutical companies, looks "light." Its product is niche cloud software, not hardware. Its value lies in its code and deep industry expertise.
Book value of all companies included in the broad market index - GURU.Markets
Model N is not a pharmaceutical company, but a creator of revenue management and pricing software for the pharmaceutical and high-tech industries. The company's assets are its software code. The company's balance sheet is the value of a "calculator" that helps real-world giants accurately price their complex products.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Model N Inc.
Model N's balance sheet is its software. Its market valuation reflects its dominant position in the niche market of revenue management software. The MvsBCap_Co chart shows the premium investors pay for sticky and indispensable software for large clients.
Market to book capitalization ratio in a market segment - It med
Model N provides cloud-based revenue management software for pharmaceutical and technology companies. The chart shows how the market values its niche expertise and ability to help clients optimize pricing and discounts.
Market to book capitalization ratio for the market as a whole
Model N provides cloud-based revenue management solutions for life sciences and high-tech companies. As a SaaS provider, its value is determined by subscriber growth and recurring payments. This chart clearly illustrates why the market values the predictability and scalability of the subscription business model, giving it a premium over its balance sheet.
Debts of the company, segment and market as a whole
MODN - Company debts Model N Inc.
For Model N, a provider of cloud-based revenue management software for pharma and high-tech companies, debt is aimed at growth in its niche. This chart shows how the company is investing in its platform to help clients navigate complex pricing and discounts. Debt is a tool for strengthening its leadership in the vertical market.
Market segment debts - It med
Model N provides cloud-based revenue management software for pharmaceutical and technology companies. This chart illustrates how a SaaS company operating in such a complex and regulated niche funds the development of its platform and how its financial structure reflects the value of its software product.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Model N Inc.
Model N is a SaaS company providing revenue management solutions for the life sciences and high-tech industries. This chart illustrates its financial strategy. Debt could have been used for acquisitions or R&D. It helps assess how stable subscription revenue for its niche software can support these liabilities.
Market segment debt to market segment book capitalization - It med
Model N provides cloud-based revenue management software for life sciences and high-tech companies. This is a critical niche software. The chart shows how the company's leverage strategy compares to overall market capitalization and financial standards in the enterprise software sector.
Debt to book value of all companies in the market
Model N (MODN) provides cloud-based revenue management software for companies in the pharmaceutical and high-tech sectors. It's a niche SaaS business. This chart shows the overall debt load of the economy. It allows you to assess how a company with stable subscription revenue manages its financial structure and whether it uses debt for growth.
P/E of the company, segment and market as a whole
P/E - Model N Inc.
For Model N, Inc., a provider of revenue management software for pharmaceutical and technology companies, this chart shows its valuation in a niche market. Its P/E is dependent on securing long-term contracts with major clients. The valuation reflects the importance of its software in adhering to complex pricing rules.
P/E of the market segment - It med
This chart shows the average P/E for enterprise software providers. For Model N, with its niche revenue management software, this is an important barometer. It helps understand how investors view its critical role for pharmaceutical customers and its ability to grow in this highly specialized market.
P/E of the market as a whole
Model N provides cloud-based revenue management software for pharmaceutical and technology companies. Its solutions help clients optimize pricing, discounts, and contracts. This chart reflects general technology trends. It helps understand whether Model N's software is mission-critical for its clients, making its revenue sustainable even during economic downturns.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Model N Inc.
Model N provides cloud-based revenue management software for pharmaceutical and technology companies. Future profits depend on how aggressively these companies adopt digital tools for complex pricing and contract management. The chart reflects analysts' growth expectations in these niche but important sectors.
%20P%2FE%20Model%20N%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Model-N-Inc.&v=1772553308710 "Chart of the company's future (projected) P/E Model N Inc.")
Future (projected) P/E of the market segment - It med
Model N, Inc. provides cloud-based revenue management solutions for pharmaceutical and technology companies. This chart shows average expectations for the IT sector. MODN's position may indicate how investors view its niche leadership and the demand for its specialized software, which helps clients optimize pricing and discounts.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-It-med&v=1772553308775 "Future (projected) P/E graph of the market segment - It med")
Future (projected) P/E of the market as a whole
Model N provides cloud-based revenue management solutions for pharmaceutical and technology companies. Demand for its software depends on the complexity of pricing in these industries. This general sentiment curve influences IT budgets, but for Model N, regulatory and market trends in its niches are more important.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772553308962 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Model N Inc.
Model N, Inc. provides cloud-based revenue management software for pharmaceutical and high-tech companies. This chart illustrates how the company profits from sophisticated price optimization. Model N's profit growth depends on the number of large clients using its platform to manage pricing, discounts, and government contracts.
Profit of companies in the market segment - It med
Model N, Inc. provides cloud-based revenue management software for pharmaceutical and technology companies. As this chart shows, MODN's profitability in the healthcare IT sector depends on the complexity of pricing and discounts in these industries. Its software helps companies optimize pricing, comply with regulations, and maximize revenue.
Overall market profit
Model N, Inc. provides revenue management software for pharmaceutical and technology companies. This is a critical tool for optimizing pricing and discounts. Demand for such solutions is robust, as they directly impact profits. This chart demonstrates that companies need to effectively manage their revenues in both growth and recession.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Model N Inc.
Model N provides cloud-based revenue management software for pharmaceutical and technology companies. This chart shows analysts' revenue forecasts, which depend on the company's ability to attract large customers and growth in its niche verticals.
%20profit%20of%20the%20company%20Model%20N%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Model-N-Inc.&v=1772553309340 "Graph of future (projected) profit of the company Model N Inc.")
Future (predicted) profit of companies in the market segment - It med
Model N, Inc. provides cloud-based revenue management software for pharmaceutical and technology companies. Its software helps optimize pricing and discounts. This chart shows the revenue forecast for the healthcare IT sector, reflecting the need for sophisticated pricing management systems in highly regulated industries.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-It-med&v=1772553309485 "Graph of future (predicted) profits of companies in a market segment - It med")
Future (predicted) profit of the market as a whole
Model N, Inc. provides revenue management software for pharmaceutical and technology companies. Demand for its solutions depends on IT budgets in these industries. Although its clients are large and established companies, during periods of severe economic downturns, even they may delay the implementation of new corporate systems, which will slow Model N's growth.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772553309530 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Model N Inc.
Model N provided cloud-based revenue management software for pharmaceutical and high-tech companies. Its revenue came from subscriptions to its niche software. The chart showed how the market valued its key role in helping clients navigate complex pricing and regulatory compliance, which ensured stable revenue.
P/S market segment - It med
Model N, Inc. provides cloud-based revenue management software for life sciences and high-tech companies, helping them optimize pricing and discounts. The chart shows the average revenue valuation in the software sector, helping to gauge how investors value its niche, yet mission-critical, software for large corporations.
P/S of the market as a whole
Model N, Inc. provides cloud-based revenue management software that helps pharmaceutical and technology companies optimize pricing and discounts. This is a critical niche. The chart helps understand the premium investors are willing to pay for a SaaS solution that directly impacts customer revenue and profitability.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Model N Inc.
Model N provides cloud-based revenue management solutions for life sciences and high-tech companies. The chart reflects the market valuation of its specialized software, comparing its price with projected future subscription revenue for its platform, which helps companies optimize pricing and discounts.
%20P%2FS%20Model%20N%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Model-N-Inc.&v=1772553309922 "The graph of the company's future (projected) P/S Model N Inc.")
Future (projected) P/S of the market segment - It med
Model N, Inc. provides cloud-based revenue management solutions for pharmaceutical and technology companies, helping them optimize pricing and discounts. This chart shows the average future revenue estimates for companies in the healthcare IT sector. It helps understand how the market values Model N's niche software and its demand among large enterprise clients.
%20P%2FS%20market%20segment%20graph%20-%20It%20med&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-It-med&v=1772553310014 "Future (projected) P/S market segment graph - It med")
Future (projected) P/S of the market as a whole
Model N, Inc. provides revenue management software for life sciences and high-tech companies. Its growth is fueled by the complexity of pricing in these industries. This graph of overall revenue expectations serves as a benchmark for the company. The key driver is its clients' need to optimize their revenue.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772553310048 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Model N Inc.
Model N provides cloud-based revenue management software for pharmaceutical and technology companies. Its revenue, shown in this chart, is generated through a subscription model. Sales growth reflects strong demand for its specialized solutions, which help clients optimize pricing and discounts.
Sales of companies in the market segment - It med
Model N, Inc. provides cloud-based revenue management software for life sciences and high-tech companies. Their platform helps optimize pricing, contracts, and discounts. This chart shows total revenue in the healthcare IT sector, reflecting the growing complexity and need for automation of commercial operations in the pharmaceutical industry.
Overall market sales
Model N provides cloud-based revenue management solutions for pharmaceutical and technology companies. Demand for its software is driven by the need for pricing optimization. This total revenue graph reflects the business activity that drives companies in complex industries to invest in specialized IT solutions.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Model N Inc.
Model N, Inc. provides cloud-based revenue management software for pharmaceutical and technology companies. The company's growth depends on these industries' need for accurate pricing and discount management. This chart shows adoption forecasts for its niche yet mission-critical SaaS solutions.
%20sales%20of%20the%20company%20Model%20N%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Model-N-Inc.&v=1772553310182 "Schedule of future (projected) sales of the company Model N Inc.")
Future (projected) sales of companies in the market segment - It med
Model N, Inc. provides cloud-based revenue management software for companies in the pharmaceutical and technology industries. Its software helps optimize pricing and discounts. The chart shows forecasts for the healthcare IT sector. The complexity of pricing in these industries creates strong demand for Model N solutions.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-It-med&v=1772553310313 "Schedule of future (projected) sales of companies in the market segment - It med")
Future (projected) sales of the market as a whole
Model N, Inc. provides cloud-based revenue management solutions for pharmaceutical and technology companies. Demand for its software is driven by the complexity of pricing and clients' desire to optimize revenue. This dynamic, reflecting business expectations, influences IT budgets and companies' willingness to invest in complex enterprise software solutions.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772553310432 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Model N Inc.
Model N, Inc. provides cloud-based revenue management software for pharmaceutical and technology companies. The profitability of this SaaS platform depends on its ability to help clients optimize pricing and discounts. This chart shows how Model N turns its niche yet critical solutions into profit.
Market segment marginality - It med
Model N, Inc. provides cloud-based revenue management solutions for life sciences and high-tech companies. This chart shows the average profitability in the software sector. Specializing in complex pricing and discounting processes in regulated industries allows the company to be an indispensable partner and maintain above-average margins.
Market marginality as a whole
Model N, Inc. provides cloud-based revenue management software for pharmaceutical and technology companies. Its solutions help optimize pricing and discounts. The profitability of this niche SaaS business depends on the complexity of the regulatory environment in its clients' industries, creating strong demand.
Employees in the company, segment and market as a whole
Number of employees in the company Model N Inc.
Model N provides cloud-based revenue management software for pharmaceutical and technology companies. It's a niche but critical SaaS business. This chart shows the size of the team of experts and developers who build and maintain this complex platform, helping these giants manage pricing.
Share of the company's employees Model N Inc. within the market segment - It med
Model N provides cloud-based revenue management software that helps pharmaceutical and high-tech companies optimize pricing and discounts. This is a critical, yet niche, task. This chart shows the share of specialists in this narrow area of enterprise software that Model N attracts, reflecting its leadership and deep expertise in its industry.
Number of employees in the market segment - It med
Model N, Inc. provides cloud-based revenue management solutions for pharmaceutical and technology companies. Headcount growth, particularly in the development and implementation departments, reflects the complexity and importance of pricing in these industries. The company is hiring specialists to support its growing client base and adapt the platform to their needs.
Number of employees in the market as a whole
Model N provides cloud-based revenue management software for pharmaceutical and high-tech companies. This chart shows how the SaaS company is growing its team to serve complex industries. The increase in consultants and developers is driven by the acquisition of new major clients and the expansion of the platform's functionality.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Model N Inc. (MODN)
Model N provides SaaS revenue management solutions for pharmaceutical and high-tech companies. It's a niche B2B software. The value lies in the code that automates complex pricing processes. This chart shows how highly the market values their scalable platform and the deep industry expertise embedded in the software, per employee.
%20of%20the%20company%20Model%20N%20Inc.%20(MODN)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Model-N-Inc.-MODN&v=1772553311097 "Chart of market capitalization per employee (in thousands of dollars) of the company Model N Inc. (MODN)")
Market capitalization per employee (in thousands of dollars) in the market segment - It med
Model N, Inc. provides cloud-based revenue management solutions for pharmaceutical and technology companies. It's a highly specialized SaaS business where value is created through code. This chart shows a high market valuation per employee, reflecting the value of their niche expertise and the scalability of their platform.
%20by%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-It-med&v=1772553311124 "Market capitalization per employee (in thousands of dollars) by market segment - It med")
Market capitalization per employee (in thousands of dollars) for the overall market
Model N, Inc. provides cloud-based revenue management software for pharmaceutical and technology companies. The chart shows the valuation of a niche SaaS company. The high cost per employee reflects that their software solves a complex and mission-critical problem for large corporations, resulting in high revenue.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772553311138 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Model N Inc. (MODN)
Model N is a SaaS company providing revenue management software for pharmaceutical and high-tech companies. They assist with pricing. This chart shows the profitability of this niche B2B software. Revenue per employee depends on the "stickiness" of their complex platform.
%20Chart%20Model%20N%20Inc.%20(MODN)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Model-N-Inc.-MODN&v=1772553311197 "Company Profit Per Employee (in thousands of dollars) Chart Model N Inc. (MODN)")
Profit per employee (in thousands of dollars) in the market segment - It med
Model N provides cloud-based revenue management software for pharmaceutical and high-tech companies. Its software helps manage complex pricing, discounts, and contracts. This chart shows how effectively the company monetizes its niche SaaS platform. It serves as a benchmark for assessing Model N's success in its vertical market.
%20in%20the%20market%20segment%20-%20It%20med&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-It-med&v=1772553311242 "Chart of profit per employee (in thousands of dollars) in the market segment - It med")
Profit per employee (in thousands of dollars) for the market as a whole
Model N ($MODN) is a SaaS company providing revenue management software for complex industries, primarily pharmaceuticals and high-tech. Their software manages pricing, discounts, and government contracts. This chart shows how effectively $MODN monetizes its niche B2B platform per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772553311254 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Model N Inc. (MODN)
Model N, Inc. provides cloud-based revenue management solutions for pharmaceutical and technology companies. This chart demonstrates the value of its niche software. The growth in revenue per employee demonstrates that its platform helps clients optimize pricing and is critical to their businesses.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Model-N-Inc.-MODN&v=1772553311307 "Sales chart per company employee Model N Inc. (MODN)")
Sales per employee in the market segment - It med
Model N (MODN) provides a highly specialized SaaS solution for revenue management (pricing, discounts, government contracts) for pharmaceutical companies and high-tech manufacturers. This graph demonstrates their niche scalability. This is complex B2B software. Their productivity depends on their ability to sell high-priced subscriptions to large corporations.
Sales per employee for the market as a whole
Model N provides SaaS solutions for revenue management (pricing, discounts) for pharmaceutical and high-tech companies. It's a niche B2B SaaS. This metric demonstrates the scalability of their model, demonstrating how effectively their engineering and sales teams generate revenue from subscriptions to their complex platform.
Short shares by company, segment and market as a whole
Shares shorted by company Model N Inc. (MODN)
Model N (MODN) is a SaaS company providing niche revenue management software for pharmaceutical and high-tech companies. This metric measures skepticism. Do the bears believe their market is too narrow, or that their clients (Big Pharma) will cut back on IT spending?
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Model-N-Inc.-MODN&v=1772553311494 "Short Shares Chart for the Company Model N Inc. (MODN)")
Shares shorted by market segment - It med
Model N, Inc. provides cloud-based revenue management software (SaaS) for companies in the high-tech and life sciences sectors. It is a niche B2B software. This chart shows the total short position in the entire enterprise software sector. If it is rising, investors expect slower growth in the sector, possibly due to reduced IT budgets at clients, which impacts MODN.
Shares shorted by the overall market
Model N provides revenue management software for pharmaceutical and tech companies. However, its business depends on IT budgets. When this indicator signals rising fear, it often foreshadows budget freezes as companies prepare for a recession by postponing software purchases, even if they promise efficiency.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Model N Inc. (MODN)
Model N is a niche but critically important SaaS provider that helps pharmaceutical and high-tech companies manage complex pricing and discounts. This indicator measured the "temperature" of their stable growth. Its recent overheating and plateau is the result of an M&A: the company was acquired (taken private) by technology fund Thoma Bravo, which valued its sticky customer base.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Model-N-Inc.-MODN&v=1772553311807 "RSI 14 indicator chart for the company's stock Model N Inc. (MODN)")
RSI 14 Market Segment - It med
Model N is "SaaS" for *prices*. Their *"cloud"* software is the "gold standard" for *revenue management* (contracts, discounts) in *complex* industries: *pharma* (Life Sciences) and *high-tech*. The "It med" sector (medical IT/SaaS) thrives on "hype." RSI_14_Seg shows the "temperature" of the *entire* industry. It helps understand: is MODN's growth a niche or a general "hype"?
RSI 14 for the overall market
Model N, a software provider for pharmaceutical companies, sees this chart as a representation of its clients' R&D budgets. In the euphoria (and the biotech boom), its clients generously finance and spend on IT infrastructure. In a panic, the biotech funding spigot is shut off, and budgets for "auxiliary" software are slashed.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast MODN (Model N Inc.)
Model N is a niche SaaS platform that helps pharma and medical technology companies manage complex pricing, contracts, and rebates. This chart shows the average Wall Street forecast. Analysts are focusing on subscription revenue growth (ARR) and customer retention in this sector.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-MODN-Model-N-Inc.&v=1772553312047 "A chart showing analyst consensus forecasts for the expected stock price. MODN (Model N Inc.)")
The difference between the consensus estimate and the actual stock price MODN (Model N Inc.)
Model N is a "financial" SaaS for Big Pharma. Their cloud platform helps pharmaceutical giants manage the *most complex* pricing, discounts, and government contracts (revenue management). This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the price and the target, reflecting their faith in this "vertical" B2B software.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-MODN-Model-N-Inc.&v=1772553312085 "A chart showing the difference between the consensus forecast and the actual stock price. MODN (Model N Inc.)")
Analyst consensus forecast for stock prices by market segment - It med
Model N (MODN) is a niche SaaS provider. Its software helps Big Pharma and high-tech companies manage complex pricing, discounts, and government contracts (revenue management). This chart shows general expectations for the healthcare IT sector. It reflects whether experts believe there will be a growing demand for pricing transparency.
Analysts' consensus forecast for the overall market share price
Model N (MODN) is an "invisible" SaaS for Big Pharma. They provide critical but highly complex software that helps pharma giants manage discounts, contracts, and government pricing. This chart reflects the overall market sentiment. It reflects analysts' confidence in the stability of IT budgets in the "defense" healthcare sector, a MODN client.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Model N Inc.
Model N is an invisible SaaS for Big Pharma. Their signature feature is ultra-niche software (Revenue Management), which automates the most complex process in pharma: calculating prices, discounts, and Medicaid reimbursements for each drug. This chart is a summary indicator of their moat. It reflects their (incredibly sticky) annual subscription revenue (ARR) from their captive customers.
AKIMA Market Segment Index - It med
Model N (MODN) is a money-making IT company focused on medical and pharma. Their software (Revenue Management) helps biotech and medical technology companies manage complex pricing, discounts, and contracts. It's niche B2B software. This chart compares their composite index to the average for the medical-IT sector.
The AKIM Index for the overall market
Model N is a provider of cloud-based revenue management solutions for the pharmaceutical and high-tech industries. Vista Equity has been privatized. This chart, reflecting the market average, is a backdrop. It helps assess how this vertical SaaS player stacks up against overall macroeconomic trends.
